Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells

被引:145
作者
Kootstra, NA
Münk, C
Tonnu, N
Landau, NR
Verma, IM [1 ]
机构
[1] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA
[2] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA
关键词
gag; cyclophilin A; gene therapy;
D O I
10.1073/pnas.0337541100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIV-1 replication in simian cells is restricted at an early postentry step because of the presence of an inhibitory cellular factor. This block reduces the usefulness of HIV-1-based lentiviral vectors in primate animal models. Here, we demonstrate that substitution of the cyclophilin A (CyPA) binding region in the capsid of an HIV-1-based lentiviral vector (LV) with that of the macrophage tropic HIV-1 Ba-L resulted in a vector that was resistant to the inhibitory effect and efficiently transduced simian cells. Notably, the chimeric gag LV efficiently transduced primary simian hematopoietic progenitor cells, a critical cellular target in gene therapy. The alterations in the CyPA binding region did not affect CyPA incorporation; however, transduction by the gag chimeric LV seemed to be relatively insensitive to cyclosporin A, indicating that it does not require CyPA for early postentry steps. In dual infection experiments, the gag chimeric LV failed to remove the block to transduction of the WT LV, suggesting that the gag chimeric LV did not saturate the inhibitory simian cellular factor. These data suggest that the CyPA binding region of capsid contains a viral determinant involved in the postentry restriction of HIV-1-based lentiviral vectors. Overall, the findings demonstrate that the host range of HIV-1-based LV can be altered by modifications in the packaging construct.
引用
收藏
页码:1298 / 1303
页数:6
相关论文
共 35 条
[1]   Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A [J].
Ackerson, B ;
Rey, O ;
Canon, J ;
Krogstad, P .
JOURNAL OF VIROLOGY, 1998, 72 (01) :303-308
[2]   Restriction of lentivirus in monkeys [J].
Besnier, C ;
Takeuchi, Y ;
Towers, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11920-11925
[3]   Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription [J].
Braaten, D ;
Franke, EK ;
Luban, J .
JOURNAL OF VIROLOGY, 1996, 70 (06) :3551-3560
[4]   Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses [J].
Braaten, D ;
Franke, EK ;
Luban, J .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4220-4227
[5]   QUIESCENT LYMPHOCYTES-T AS AN INDUCIBLE VIRUS RESERVOIR IN HIV-1 INFECTION [J].
BUKRINSKY, MI ;
STANWICK, TL ;
DEMPSEY, MP ;
STEVENSON, M .
SCIENCE, 1991, 254 (5030) :423-427
[6]   Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism [J].
Cowan, S ;
Hatziioannou, T ;
Cunningham, T ;
Muesing, MA ;
Gottlinger, HG ;
Bieniasz, PD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11914-11919
[7]   Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function [J].
Demirov, DG ;
Ono, A ;
Orenstein, JM ;
Freed, EO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :955-960
[8]   Identification of a major co-receptor for primary isolates of HIV-1 [J].
Deng, HK ;
Liu, R ;
Ellmeier, W ;
Choe, S ;
Unutmaz, D ;
Burkhart, M ;
DiMarzio, P ;
Marmon, S ;
Sutton, RE ;
Hill, CM ;
Davis, CB ;
Peiper, SC ;
Schall, TJ ;
Littman, DR ;
Landau, NR .
NATURE, 1996, 381 (6584) :661-666
[9]   Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element [J].
Donello, JE ;
Loeb, JE ;
Hope, TJ .
JOURNAL OF VIROLOGY, 1998, 72 (06) :5085-5092
[10]   The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811 [J].
Dorfman, T ;
Gottlinger, HG .
JOURNAL OF VIROLOGY, 1996, 70 (09) :5751-5757